Author:
Rudko O. I.,Sergeeva N. I.,Andreeva L. A.,Danilova R. A.
Subject
General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology
Reference33 articles.
1. Raiteri, M., Maura, G., Bonanno, G., and Pittaluga, A., Differential Pharmacology and Function of Two 5-HT1 Receptors Modulating Transmitter Release in Rat Cerebellum, Pharmacol. Exp. Ther., 1986, vol. 237, no. 2, pp. 644–648.
2. Maura, G. and Raiteri, M., Cholinergic Terminals in Rat Hippocampus Possess 5-HT1B Receptors Mediating Inhibition of Acetylcholine Release, Europ. J. Pharmacol., 1986, vol. 129, no. 3, pp. 333–337.
3. Grimaldi, B., Bonnin, A., Fillion, M.P., Prudhomme, N., and Fillion, G., 5-Hydroxytryptamine-Moduline: a Novel Endogenous Peptide Involved in the Control of Anxiety, Neuroscience, 1999, vol. 93, no. 4, pp. 1223–1225.
4. Sarhan, H., Gloez-Tayarani, I., Massot, O., Fillion, M.P., and Fillions, G., 5-HT1B Receptors Modulate Release of [3H]Dopamine from Rat Striatal Synaptosomes, Naunyn-Schmiedebergs Arch. Pharmacol., 1999, vol. 359, no. 1, pp. 40–47.
5. Moret, C., Grimaldi, B., Massot, O., and Fillion, G., The Role and Therapeutic Potencial of 5-HT-Moduline in Psychiatry, Semin. Clin. Neuropsychiatry, 2003, vol. 8, no. 2, pp. 137–146.